WallStreetZenWallStreetZen

NASDAQ: LGND
Ligand Pharmaceuticals Inc Stock Ownership - Who owns Ligand Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Ligand Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Andrew ReardonCLO Secretary2026-07-01700$313.46
$219.42kSell
Andrew ReardonCLO Secretary2026-07-011,119$311.72
$348.81kSell
Andrew ReardonCLO Secretary2026-07-01600$317.15
$190.29kSell
Andrew ReardonCLO Secretary2026-07-01900$315.78
$284.20kSell
Andrew ReardonCLO Secretary2026-07-01100$314.58
$31.46kSell
Andrew ReardonCLO Secretary2026-07-011,081$312.28
$337.57kSell
Andrew ReardonCLO Secretary2026-07-015,000$52.27
$261.35kBuy
Andrew ReardonCLO Secretary2026-07-01396$308.99
$122.36kSell
Andrew ReardonCLO Secretary2026-07-01104$310.20
$32.26kSell
Octavio EspinozaChief Financial Officer2026-06-3017$160.71
$2.73kBuy

1 of 17

LGND insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LGND insiders and whales buy or sell their stock.

LGND Shareholders

What type of owners hold Ligand Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bvf Partners L P316.02%63,334,719$18.62BInsider
David M. Knott62.93%12,611,277$3.71BInsider
Daniel S. Loeb48.67%9,754,756$2.87BInsider
Investment 10 LLC17.87%3,582,065$1.05BInsider
Blackrock Inc14.78%2,961,923$870.78MInstitution
Vanguard Portfolio Management LLC5.49%1,100,267$323.47MInstitution
Janus Henderson Group PLC5.04%1,009,891$296.90MInstitution
Vanguard Capital Management LLC4.23%848,089$249.33MInstitution
Invesco Ltd4.11%823,604$242.13MInstitution
State Street Corp3.89%778,856$228.98MInstitution

1 of 3

LGND vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LGND18.49%81.51%Net SellingNet Selling
SRRK61.89%38.11%Net BuyingNet Buying
ERAS76.07%23.93%Net Buying
CGON85.88%14.12%Net BuyingNet Buying
BLTE23.17%1.05%Net SellingNet Selling
View Top Biotech Stocks

Ligand Pharmaceuticals Stock Ownership FAQ

Who owns Ligand Pharmaceuticals?

Ligand Pharmaceuticals (NASDAQ: LGND) is owned by 103.75% institutional shareholders, 457.36% Ligand Pharmaceuticals insiders, and 0.00% retail investors. Bvf Partners L P is the largest individual Ligand Pharmaceuticals shareholder, owning 63.33M shares representing 316.02% of the company. Bvf Partners L P's Ligand Pharmaceuticals shares are currently valued at $19.35B.

If you're new to stock investing, here's how to buy Ligand Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.